Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis Raises 2013 Forecast on Lack of Diovan Generic
Bloomberg
Tue, 10/22/13 - 08:11 am
Tags:
Novartis, guidance, Diovan
Novartis advances rival CDK 4/6 cancer drug to Pfizer's palbociclib
Fierce Biotech
Mon, 10/21/13 - 05:55 pm
Tags:
Novartis, cyclin-dependent kinase inhibition [CDK], Pfizer, palbociclib, LEE011
Atchoo! Who’s making money out of flu season
CNBC
Fri, 10/18/13 - 09:34 am
Tags:
Flu, Novartis, GSK, Merck, Sanofi, AstraZeneca
Cleveland Clinic picks top 3 blockbuster drug candidates in the late-stage pipeline
Fierce Biotech
Thu, 10/17/13 - 06:18 pm
Tags:
Cleveland Clinic, JNJ, Pharmacyclics, Novartis, serelaxin, ibrutinib, sofosbuvir, Gilead
3 Pipeline Drugs That Could Have a Dramatic Impact on Parkinson's Disease by 2020
Motley Fool
Thu, 10/17/13 - 08:24 am
Tags:
Parkinson's Disease, pimavanserin, Acadia, Duodopa, AbbVie, LCIG, AFQ056, Novartis
Top 10 Drugmakers in Emerging Markets
Fierce Pharma
Mon, 10/14/13 - 10:31 am
Tags:
emerging markets, Bayer, Sanofi, Merck KGaA, GSK, Novartis, JNJ, Novo Nordisk, AstraZeneca, Pfizer, Roche
The Big Bucks in Keeping Kids Focused
Bloomberg/Businessweek
Fri, 10/11/13 - 08:50 am
Tags:
ADHD, Shire, Vyvanse, Novartis, JNJ, Europe
Novartis - Make Money From COPD Opportunity
Seeking Alpha
Tue, 10/8/13 - 05:06 pm
Tags:
COPD, Novartis, GSK, Theravance, Pfizer, Ultibro Breezhaler
Supreme Court Rejects Novartis Bid To Hear Punitive Damages Case
Pharmalot
Tue, 10/8/13 - 08:37 am
Tags:
Novartis, Supreme Court, FDA
Novartis' omalizumab shines in third PhIII hives trial
Pharma Times, UK
Mon, 10/7/13 - 08:52 am
Tags:
Novartis, chronic spontaneous urticaria, omalizumab, Xolair, Genentech
Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill
Seeking Alpha
Mon, 10/7/13 - 08:48 am
Tags:
Rexahn, chemotherapy, Amgen, Bristol-Myers Squibb, Merck, Novartis, Teva, RX-3117
Should Drugmakers Pay Punitive Damages? Novartis Says No Comment Now Follow Comments
Forbes
Sat, 10/5/13 - 09:51 am
Tags:
Novartis, lawsuits
2 Companies Suffering From Generic Competition and 1 That's Set to Benefit
Motley Fool
Sat, 10/5/13 - 09:50 am
Tags:
Novartis, generics, GSK, Ranbaxy
2 Companies Suffering From Generic Competition and 1 That's Set to Benefit
Motley Fool
Fri, 10/4/13 - 12:13 pm
Tags:
generics, GSK, Novartis, Ranbaxy
Should Drugmakers Pay Punitive Damages? Novartis Says No
Pharmalot
Fri, 10/4/13 - 11:23 am
Tags:
Novartis
New class of psoriasis drugs being developed
Bloomberg
Fri, 10/4/13 - 10:14 am
Tags:
psoriasis, Novartis, AstraZeneca, Amgen, Eli Lilly, Enbrel, secukinumab, brodalumab, IL-17 blockers
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
Tags:
drug launches, Eylea, Regeneron, Bayer, Tecfidera, Biogen Idec, Kalydeco, Vertex Pharmaceuticals, Kadcyla, Roche, Genentech, Victoza, Novo Nordisk, Gilenya, Novartis, Zytiga, JNJ, Yervoy, Bristol-Myers Squibb, Stribild, Gilead Sciences Xtandi, Medivation, Astellas, Afinitor, Amgen, Prolia, Stelara, Kyprolis, Xarelto, ONYX Pharmaceuticals
Novartis sees limited impact from Japan Diovan scandal
Reuters
Thu, 10/3/13 - 09:11 am
Tags:
Novartis, Japan, Diovan
Incyte Has First-Mover Advantage
Motley Fool
Wed, 10/2/13 - 10:10 am
Tags:
Incyte, myelofibrosis, Jakafi, Novartis
Novartis May Have Violated Japanese Law With Diovan Marketing
Pharmalot
Tue, 10/1/13 - 10:12 am
Tags:
Japan, Diovan, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.